Skip to content

Public FDA record

Z-1150-2020: ROSA Brain 3.0 Application-Brain

Recall record Z-1150-2020 for MEDTECH SAS. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1150-2020
Company in FDA record
MEDTECH SAS
FDA record creation date
Feb 11, 2020
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Some cross-sectional images from the image acquisitions of the patients head may not be reconstructed/displayed properly in two and three dimension views when using ROSA Brain software, potentially compromising the surgery planning.

Source facts

Action
On January 6, 2020, Zimmer Biomet issued URGENT MEDICAL DEVICE CORRECTION notices to customers via FedEx. Actions Required By Users: Your device can continue to be used, as long as the recommendations below are followed: While the current Instructions For Use do not require the images to be reviewed with ROSA Brain software prior to surgery, they adequately describe the standard workflow and indicate that the image acquisition of the patients head (MRI / CT or 2D X-Ray images) is performed prior to surgery, and is then loaded into the device and used by the surgeon in the preoperative phase to carry out the surgical planning. Due to this potential image management issue, Zimmer Biomet recommends that images be reviewed using the ROSA Brain software prior to surgery. If an issue is detected with the reconstruction and display of the images using the ROSA software, and if the artifacts are located in the Region Of Interest and prevent the surgical planning, then the surgery might have to be cancelled or converted to traditional surgery. However, if the artifacts are not located inside the Region Of Interest and if the surgery planning is successful, the affected device can continue to be used. Transmission of the Medical Device Correction: Please advise the appropriate personnel working in your department with the ROSA system of the content of the letter. Risk Manager Responsibilities: 1. Review the notification and ensure affected personnel are aware of the contents. 2. Complete the Certificate of Acknowledgement. a. Return a digital copy to CorporateQuality.PostMarket@zimmerbiomet.com. b. Retain a copy of the Acknowledgement Form with your field action records in the event of a compliance audit of your facilities documentation. 3. If you have further questions or concerns after reviewing the notice, please call Perry Twyford at 281-389-3236 between 9:00 am and 6:00pm EST, Monday through Friday. Alternatively, your questions may be e
Initiated
2020-01-06
Root cause
Software design
Terminated
2020-11-05
Distribution
US Nationwide
Recall number
Z-1150-2020
Recall status
Terminated
CDRH record ID
178881
FDA record created
2020-02-11
Recall event number
84642

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗